From Wikidoc - Reading time: 5 min
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Trolamine Salicylate is an analgesic that is FDA approved for the treatment of musculoskeletal pain and osteoarthritis. Common adverse reactions include erythema, skin irritation.
There is limited information regarding Trolamine Salicylate Contraindications in the drug label.
For external use only
Allergy alert: If prone to allergic reaction from aspirin or salicylates, consult a doctor before use.
When using this product
Stop use and ask a doctor if
If pregnant or breast-feeding
Keep out of reach of children.
There is limited information regarding Clinical Trial Experience of Trolamine Salicylate in the drug label.
There is limited information regarding Postmarketing Experience of Trolamine Salicylate in the drug label.
There is limited information regarding Trolamine Salicylate Drug Interactions in the drug label.
Pregnancy Category (FDA):
There is no FDA guidance on usage of Trolamine Salicylate in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Trolamine Salicylate in women who are pregnant.
There is no FDA guidance on use of Trolamine Salicylate during labor and delivery.
There is no FDA guidance on the use of Trolamine Salicylate with respect to nursing mothers.
There is no FDA guidance on the use of Trolamine Salicylate with respect to pediatric patients.
There is no FDA guidance on the use of Trolamine Salicylate with respect to geriatric patients.
There is no FDA guidance on the use of Trolamine Salicylate with respect to specific gender populations.
There is no FDA guidance on the use of Trolamine Salicylate with respect to specific racial populations.
There is no FDA guidance on the use of Trolamine Salicylate in patients with renal impairment.
There is no FDA guidance on the use of Trolamine Salicylate in patients with hepatic impairment.
There is no FDA guidance on the use of Trolamine Salicylate in women of reproductive potentials and males.
There is no FDA guidance one the use of Trolamine Salicylate in patients who are immunocompromised.
Adults and children over 12 years:
There is limited information regarding Monitoring of Trolamine Salicylate in the drug label
There is limited information regarding IV Compatibility of Trolamine Salicylate in the drug label.
There is limited information regarding Chronic Overdose of Trolamine Salicylate in the drug label.

There is limited information regarding Mechanism of Action of Trolamine Salicylate in the drug label.
There is limited information regarding Structure of Trolamine Salicylate in the drug label.
There is limited information regarding Pharmacodynamics of Trolamine Salicylate in the drug label.
There is limited information regarding Pharmacokinetics of Trolamine Salicylate in the drug label.
There is limited information regarding Nonclinical Toxicology of Trolamine Salicylate in the drug label.
There is limited information regarding Clinical Studies of Trolamine Salicylate in the drug label.
There is limited information regarding Trolamine Salicylate How Supplied in the drug label.
There is limited information regarding Trolamine Salicylate Storage in the drug label.
{{#ask: Page Name::Trolamine Salicylate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}


{{#ask: Label Page::Trolamine Salicylate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
There is limited information regarding Patient Counseling Information of Trolamine Salicylate in the drug label.
The contents of this FDA label are provided by the National Library of Medicine.
|title= (help)
{{#subobject:
|Page Name=Trolamine Salicylate
|Pill Name=No image.jpg
|Drug Name=
|Pill Ingred=|+sep=;
|Pill Imprint=
|Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
|Pill Color=|+sep=;
|Pill Shape=
|Pill Size (mm)=
|Pill Scoring=
|Pill Image=
|Drug Author=
|NDC=
}}
{{#subobject:
|Label Page=Trolamine Salicylate |Label Name=Trolamine Salicylate11.png
}}
{{#subobject:
|Label Page=Trolamine Salicylate |Label Name=Trolamine Salicylate11.png
}}